Skip to main content
SpringerLink
Log in

Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats

  • Laboratory Investigations
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

Summary

The study was designed to determine the skeletal effects of withdrawal of estrogen and diphosphonate treatment in the estrogen-deplete state. Groups of ovariectomized (OVX) rats were treated with vehicle alone, estrogen, or the diphosphonates etidronate or risedronate for a 180-day period. A group of sham-operated control rats was treated for 180 days with vehicle alone. All treatments were then terminated, followed by sequential sacrifice of rats at 0, 35, 90, 180, and 360 days after withdrawal of treatment. The proximal tibia from each animal was processed undecalcified for quantitative bone histomorphometry. At the end of the treatment period, vehicle-treated OVX rats were characterized by cancellous osteopenia and increased bone turnover relative to vehicle-treated control rats. Treatment of OVX rats with estrogen or diphosphonates depressed bone turnover and protected against cancellous osteopenia. During the withdrawal period, OVX rats previously treated with estrogen exhibited rapid bone loss associated with increased bone turnover. The bone protective effect of the hormone in OVX rats was nearly completely lost by 90 days of withdrawal. In contrast, OVX rats maintained low levels of bone turnover and normal cancellous bone mass at 180 days of withdrawal from diphosphonate treatment. The results suggest that estrogen-deplete women who are withdrawn from estrogen replacement are at high risk for subsequent bone loss. They further suggest that widely spaced periods of intermittent diphosphonate treatment may be sufficient to prevent the development of osteopenia in postmenopausal and oophorectomized women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Horsman A, Simpson M, Kirby PA, Nordin BEC (1977) Non-linear bone loss in oophorectomized women. Br J Radiol 50:504–507

    Google Scholar 

  2. Elders PJM, Netelenbos JC, Lips P, van Ginkel FC, van der Stelt PJ (1988) Accelerated vertebral bone loss in relation to the menopause. Bone Miner 5:11–19

    Google Scholar 

  3. Nilas L, Christiansen C (1988) Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 18:529–534

    Google Scholar 

  4. Stepan JJ, Pospichal J, Presl J, Pacovsky V (1987) Bone loss and biochemical indices of bone remodeling in surgically-induced postmenopausal women. Bone 8:279–284

    Google Scholar 

  5. Kelly PJ, Pocock NA, Sambrook PN, Eisman JA (1989) Age and menopause-related changes in indices of bone turnover. J Clin Endocrinol Metab 69:1160–1165

    Google Scholar 

  6. Recker RR, Saville PD, Heaney RP (1977) Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann Int Med 87:649–655

    Google Scholar 

  7. Christiansen C, Christensen MS, Larsen NE, Transbol I (1982) Pathophysiological mechanisms of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrinol Metab 55:1124–1130

    Google Scholar 

  8. Steineche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F (1989) A randomized study on the effects of estrogen/ gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone 10:313–320

    Google Scholar 

  9. Smith ML, Fogelman I, Hart DM, Scott E, Bevan J, Leggate I (1989) Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int 44:74–79

    Google Scholar 

  10. Reginster JY, Lecart MP, Deroisy R, Sarlet N, Denis D, Ethgen D, Collette J, Franchimot P (1989) Prevention of postmenopausal bone loss by tiludronate. Lancet 2:1469–1471

    Google Scholar 

  11. Lindsay R, MacLean A, Kraszewski A, Hart DM, Clark AC, Garwood J (1978) Bone response to termination of estrogen treatment. Lancet 2:1325–1327

    Google Scholar 

  12. Christiansen C, Christensen MS, Transbol I (1981) Bone mass in postmenopausal women after withdrawal of estrogen/gestagen replacement therapy. Lancet 1:459–461

    Google Scholar 

  13. Wronski TJ, Cintrón M, Dann LM (1988) Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int 43:179–183

    Google Scholar 

  14. Wronski TJ, Cintrón M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681–686

    Google Scholar 

  15. Turner RT, Wakley GK, Hannon KS, Bell NH (1988) Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian-hormone deficient rats. Endocrinology 122:1146–1150

    Google Scholar 

  16. Kalu DN, Liu CC, Salerno E, Hollis B, Echon R, Ray M (1991) Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175–187

    Google Scholar 

  17. Wronski TJ, Yen C-F, Scott KS (1991) Estrogen and diphosphonate treatment provide long-term protection against osteopenia in ovariectomized rats. J Bone Miner Res 6:387–394

    Google Scholar 

  18. Seedor JG, Quartuccio HA, Thompson DD (1991) The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6:339–346

    Google Scholar 

  19. Wronski TJ, Schenck PA, Cintrón M, Walsh CC (1987) Effect of body weight on osteopenia in ovariectomized rats. Calcif Tissue Int 40:155–159

    Google Scholar 

  20. Baron R, Vignery A, Neff L, Silvergate A, Santa Maria A (1983) Processing of undecalcified bone specimens for bone histomorphometry. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL, pp 13–35

    Google Scholar 

  21. Frost HM (1983) Bone histomorphometry: analysis of trabecular bone dynamics. In: Recker RR (ed) Bone histomorphometry: techniques and interpretation. CRC Press, Boca Raton, FL, pp 109–132

    Google Scholar 

  22. Frost HM (1977) Histomorphometry of trabecular bone: Theoretical correction of appositional rate measurement. In: Meunier PJ (ed) Bone histomorphometry. Societe de la Nouvelle Imprimerie Fournie, Toulouse, France, pp 361–370

    Google Scholar 

  23. Conover WJ (1980) Practical nonparametric statistics. John Wiley and Sons, New York, pp 229–237

    Google Scholar 

  24. Fleisch H (1987) Bisphosphonates-history and experimental basis. Bone 8(Suppl 1):S23-S28

    Google Scholar 

  25. Frost HM (1979) Treatment of osteoporoses by manipulation of coherent bone cell populations. Clin Orthop 143:227–244

    Google Scholar 

  26. Anderson C, Cape RDT, Grilly RG, Hodsman AB, Wolfe BMJ (1984) Preliminary observations of a form of coherence therapy for osteoporosis. Calcif Tissue Int 36:341–343

    Google Scholar 

  27. Pacifici R, McMurtry C, Vered I, Rupich R, Avioli LV (1988) Coherence therapy does not prevent axial bone loss in osteoporotic women: a preliminary comparative study. J Clin Endocrinol Metab 66:747–753

    Google Scholar 

  28. Hodsman AB (1989) Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. Bone Miner 5:201–212

    Google Scholar 

  29. Miller SC, Jee WSS (1979) The effect of dichloromethylene diphosphonate, a pyrophosphate analog, on bone and bone cell structure in the growing rat. Anat Rec 193:439–461

    Google Scholar 

  30. Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson DD, Golub E, Rodan GA (1991) Bisphosphonate action: alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88:2095–2105

    Google Scholar 

  31. Wronski TJ, Dann LM, Scott KS, Cintrón M (1989) Long-term effects of ovariectomy and aging on the rat skeleton. Calcif Tissue Int 45:360–366

    Google Scholar 

  32. Li XJ, Jee WSS, Chow S-Y, Woodbury DM (1990) Adaptation of cancellous bone to aging and immobilization in the rat: a single photon absorptiometry and histomorphometric study. Anat Rec 227:12–24

    Google Scholar 

  33. Delmas PD, Stenner D, Wahner HW, Mann KG, Riggs BL (1983) Increase in serum bone gamma-carboxyglutamic acid protein with aging in women. J Clin Invest 71:1316–1321

    Google Scholar 

  34. Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL (1988) Bone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67:741–748

    Google Scholar 

  35. Kotowicz MA, Melton LJ, Cedel SL, O'Fallon WM, Riggs BL (1990) Effect of age on variables relating to calcium and phosphorus metabolism in women. J Bone Miner Res 5:345–352

    Google Scholar 

  36. Gallagher JC, Riggs BL, Jerpbak CM, Arnaud CD (1980) The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J Lab Clin Med 95:373–385

    Google Scholar 

  37. Armbrecht HJ, Forte LR, Halloran BP (1984) Effect of age and dietary calcium on renal 25-OH-D metabolism, serum 1,25(OH)2D, and PTH. Am J Physiol 246:E266-E270

    Google Scholar 

  38. Kalu DN, Masoro EJ, Yu BP, Hardin RR, Hollis BW (1988) Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 122:1847–1854

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiological Sciences, College of Veterinary Medicine, JHMHC, University of Florida, Box 100144, 32610, Gainesville, Florida, USA

    T. J. Wronski, L. M. Dann, H. Qi & C. -F. Yen

Authors
  1. T. J. Wronski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. M. Dann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. -F. Yen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wronski, T.J., Dann, L.M., Qi, H. et al. Skeletal effects of withdrawal of estrogen and diphosphonate treatment in ovariectomized rats. Calcif Tissue Int 53, 210–216 (1993). https://doi.org/10.1007/BF01321840

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01321840

Key words

Search

Navigation